Showing results (371-380 of 470) with videos related to
Sort By:
Pageof 47
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 28, 2009
Initial experience with lung donation after cardiocirculatory death in CanadaMarcelo Cypel, Masaaki Sato, Erkan Yildirim, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2013
Pilot study exploring lung allograft surfactant protein A (SP-A) expression in association with lung transplant outcomeF D'Ovidio, H Kaneda, C Chaparro, et al.Stem Cells Translational Medicine|March 31, 2016
Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid ArthritisGali Shalev-Malul, David C Soler, Anthony E Ting, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 3, 2021
Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipientsLiran Levy, Ella Huszti, Musawir Ahmed, et al.ERJ Open Research|October 11, 2023
Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipientsRayoun Ramendra, Juan C Fernández-Castillo, Ella Huszti, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 24, 2021
A simplified strategy for donor-recipient size-matching in lung transplant for interstitial lung diseasePeter Riddell, Jin Ma, Ben Dunne, et al.Transplantation|April 30, 1999
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipientsD C Brennan, K Flavin, J A Lowell, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2021
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of AnaphylaxisMarcus Shaker, Elizabeth Phillips, Kimberly G Blumenthal, et al.Arthritis and Rheumatism|August 29, 2009
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritisE H Giannini, N T Ilowite, D J Lovell, et al.Clinical Transplantation|May 27, 2015
Simkania negevensis and acute cellular rejection in lung transplant recipientsAlainna J Jamal, Mariangela R Resende, Taisa Prochnow, et al.Pageof 47